Agoracom Blog Home

Posts Tagged ‘small cap stocks’

INTERVIEW: TransCanna $TCAN.ca License Creates One Of California’s Largest Fully Licensed Cannabis Facilities $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 8:12 PM on Sunday, July 12th, 2020
tcan-square

TransCanna Holdings (TCAN:CSE) is part of the New Cannabis Kids On The Block wave that investors are demanding after mega financed companies flopped last year.  TCAN, on the other hand, is delivering the following to investors: 

·  $2M CAD Revenue April 2020 

·  $24.6M CAD Revenue Run Rate solely from TransCanna test facility 

·  $90M Annual Revenue expected from first full year upon completion of 196,000 Sq Ft Daly facility Q3 2021 

·  Daly facility will be one of the largest cannabis facilities in California 

And today the story got even better, with TCAN announcing that its wholly-owned subsidiary was granted a “Type 11 Distributor License” by the California Bureau of Cannabis Control for its 196,000 square foot Daly Avenue Facility. 

HUGE BUSINESS IMPLICATIONS – TRANSCANNA POSITIONED TO BECOME PART OF NEW LEADERSHIP GROUP IN CANNABIS  

As a result, Trancanna now owns the largest known, fully licensed cannabis facility in California.  Given the fact TCAN is processing more than $USD 1,000,000/month in wholesale cannabis transactions out of a distribution space of just 1,000 square feet, the implications for Daly expanding to 196,000 square feet are HUGE in the areas of:  

  • Capacity 
  • Revenue
  • Reach
  • …. much more 

The first round of cannabis leaders disappointed investors and created significant value destruction in the space.  But like every new mega industry that goes through a catharsis stage, the next round of growth gives birth to the best and potentially biggest players for the long haul.

The next 24 – 36 months are going to be fun for TCAN.  How fun?  Watch this interview with CEO Bob Blink.

Watch this interview or listen by Podcast on AppleGoogleSpotify or your favourite podcaster.

CLIENT FEATURE: Binovi Technologies $VISN.ca Creating Faster Brains Through Stronger Eyes $EYPT $KALA

Posted by AGORACOM-JC at 4:00 PM on Monday, July 6th, 2020
http://www.smallcapepicenter.com/binovi%20square.png

Trusted and used by some of the world’s top professional sports teams, including:

Why Binovi?

  • Binovi Has Already Started Commercializing Its Vision Therapy Platform
  • Company’s Vision Therapy Products Used In:
    • Over 1,500 Practices
    • 20 Countries
  • Flagship “Binovi” Is State-Of-The-Art Platform
    • Measures 14 Key Vision Skills
    • Essential For Maximizing Brain Performance
    • Shipped Over 400 Binovi Units (April 2020)
    • Goal Is 2,500 Binovi Units (End Of 2020)
  • Signed Sports Vision Partnership With Eli Wilson Goaltending
    • World Leader In Goaltending Development
    • 600 Active Goaltending Camp Participants
    • 50,000 Global Aspiring Goaltenders
  • Binovi is now well positioned to further commercialize and capitalize on massive demand for Vision Therapy and Training For Athletes and Education

THE MARKET OPPORTUNITY

  • Vision Therapy captures 3% of a $36B Yearly Vision Market today
  • Vision Therapy will grow by 22% this year and account for 4% of the $39B Yearly Market by year end
  • Sights are set on disrupting the sports performance industry in 2020 while receiving engagement from leaders within the human performance – sport performance industry
  • The size of the sports performance market reached a value of nearly $488.5B in 2018, having grown at a compound annual growth rate (CAGR) of 4.3% since 2014
  • Expected to grow at a CAGR of 5.9% to nearly $614.1B by 2022

Binovi Explained

Binovi Technologies is an advertising client of AGORA Internet Relations Corp.

Digital Health #Mhealth Funding Shatters Funding Records Despite #COVID Economy – SPONSOR: CardioComm Solutions $EKG.ca $ATE.ca $TLT.ca $OGI.ca $ACST.ca $IPA.ca

Posted by AGORACOM-JC at 3:40 PM on Monday, July 6th, 2020

SPONSOR: CardioComm Solutions (EKG: TSX-V) – The heartbeat of cardiovascular medicine and telemedicine. Patented systems enable medical professionals, patients, and other healthcare professionals, clinics, hospitals and call centres to access and manage patient information in a secure and reliable environment.

Digital Health Funding Shatters Funding Records Despite COVID Economy

  • Despite COVID-19, digital health funding shattered all previous venture capital funding records for the sector by raising $6.3 billion in the first half of the year (1H), according to Mercom Capital Group.
  • The Austin, TX-based firm reported that the digital health funding in 1H was 24% higher than the $5.1 billion the space raised in the first half of 2019, despite the pandemic disrupting the economy

By: Amanda Pedersen

Despite COVID-19, digital health funding shattered all previous venture capital funding records for the sector by raising $6.3 billion in the first half of the year (1H), according to Mercom Capital Group.

The Austin, TX-based firm reported that the digital health funding in 1H was 24% higher than the $5.1 billion the space raised in the first half of 2019, despite the pandemic disrupting the economy. Mercom Capital Group is previewewed this data in advance of its upcoming 1H Digital Health Funding and M&A Report, which is expected to be published July 13.

Interestingly enough, venture funding reached $2.8 billion during the second quarter of 2020, an 11% decrease year-over-year compared to $3.1 billion raised in Q2 2019. Healthcare practice-centric digital health companies received 34% of the funding in Q2 2020, raising $947 million in 56 deals, and consumer-centric digital health companies accounted for 66% of the funding, raising $1.8 billion in 105 deals.

“Adoption of digital health technologies and products have accelerated since the COVID-19 outbreak, which is reflected in the funding spike in the first half of the year. Telehealth hype has been backed by $2 billion in venture funding with no signs of slowing down,” said Raj Prabhu, CEO of Mercom Capital Group.

This confirms what MD+DI has previously reported regarding telemedicine trends that emerged during the early days of the pandemic.

Other categories that received significant funding during the second quarter include mHealth apps, analytics, wellness, and medical imaging, Mercom reported.

The top-funded digital health categories in 1H 2020 were: telehealth with $1.9 billion, followed by analytics with $826 million, mHealth apps with $794 million, clinical decision support with $545 million, healthcare service booking with $326, and wearable sensors with $321 million.

The top telehealth VC deals in 1H 2020 included: $194 million raised by Amwell (formerly American Well), $155 million raised by KRY, $144 million raised by Zhiyun Health, $100 million raised by Mindstrong, and $93 million raised by Virta Health. Telehealth funding was distributed in 85 companies during 1H 2020.

The top overall digital health VC deals in 1H 2020 included: $285 million raised by ClassPass, $250 million raised by Alto Pharmacy, $194 million raised by Amwell, $155 million raised by KRY, and $150 million raised by Concerto HealthAI. Digital Health funding was distributed in 27 different countries in 1H 2020.

Mercom Capital Group is a global communications and consulting firm that produces funding and market intelligence reports covering a variety of “cleantech” sectors.

Source: https://www.mddionline.com/digital-health/digital-health-funding-shatters-funding-records-despite-covid-economy

Eyecarrot $EYC.ca Announces Change of Name to Binovi Technologies Corp and the Postponement of Annual Financial Statements $EYPT $KALA

Posted by AGORACOM-JC at 12:38 PM on Monday, June 29th, 2020
http://www.smallcapepicenter.com/eyc%20square.png
  • Announced that its Board of Directors has approved a name change from Eyecarrot Innovations Corp. to Binovi Technologies Corp.
  • In connection with the name change, the Company’s trading symbol on the TSX Venture Exchange will be changed to ‘VISN’
  • It is expected that the name change will be effected on or about June 30, 2020 and the Company’s common shares will begin trading under the new name and symbol upon market open on Thursday July 2, 2020, subject to final approval by TSXV

June 29, 2020 – Toronto, New York – Eyecarrot Innovations Corp., (Eyecarrot) (TSXV:EYC) | (OTC:EYCCF) | (2EYA:GR) a leader is neuro-vision performance technology, announces that its Board of Directors has approved a name change from Eyecarrot Innovations Corp. to Binovi Technologies Corp. In connection with the name change, the Company’s trading symbol on the TSX Venture Exchange (“TSXV”) will be changed to ‘VISN’. It is expected that the name change will be effected on or about June 30, 2020 and the Company’s common shares will begin trading under the new name and symbol upon market open on Thursday July 2, 2020, subject to final approval by TSXV. The CUSIP number assigned to the Company’s shares following the name change is 09076N109 (ISIN: CA09076N1096). No action is required to be taken by shareholders with respect to the name change. Outstanding share and warrant certificates are not affected by the name change and do not need to be exchanged.

Postponement of Annual Financial Statements

The Company announces the postponement of filing its annual financial statements and management’s discussion and analysis (collectively the “Annual Statements”) for the year ended February 29, 2020 due to logistics and delays caused by the COVID-19 pandemic.

The Company is relying on exemptive relief granted by Canadian securities regulatory authorities that allows it to delay the filing of its Annual Statements required by sections 4.2 and 5.12(2) of National Instrument 51-102 due to be filed by June 29, 2020. In response to the coronavirus disease pandemic, securities regulatory authorities in Canada have granted a blanket exemption allowing issuers an additional 45 days to complete their regulatory filings.

Eyecarrot anticipates that its Annual Statements will be available for filing at its earliest opportunity, which is expected to occur on or before August 12, 2020. Until such time as the Annual Statements are filed, the Company’s management and insiders are subject to a trading blackout that reflects the principals contained in section 9 of National Policy 11-207 – Failure-to-File Cease Trade Orders and Revocations in Multiple Jurisdictions.

Other than as previously disclosed by the Company in news releases, there have been no material business developments since the date of the last interim financial statements filed on January 30, 2020, copies of which are available under the Company’s profile on SEDAR at www.sedar.com. The Company will be providing an update news release on the status of filing its February 29, 2020 audited financial statements and its May 30, 2020 first quarter unaudited financial statements by July 29, 2020.

AGORACOM Agreement

The Company announces that further to its news release dated April 28, 2020, it will make its first issuance of shares under its online marketing and awareness program with Agora Internet Relations Corp. (“AGORACOM”). Pursuant to this first tranche, the Company will issue 52,154 common shares of the Company at a deemed price of $0.26. AGORACOM’s program includes a “CEO Verified” Discussion Forum. The forum serves as the Company’s primary social media platform to interact with both shareholders and the broader investment community in a fully moderated environment.

The Eyecarrot HUB can be found at https://agoracom.com/ir/EyecarrotInnovations

For additional information on the Company, please visit https://www.eyecarrot.com/investors/

About Binovi by Eyecarrot

Eyecarrot Innovations Corp. is a human performance technology company that has developed Binovi, a hardware and software-centered platform. Binovi combines hardware, software, specialized expert knowledge, and unique big data insights in order to deliver customized one-on-one training and treatment. Binovi is designed for vision optimization and the enhancement of cognitive skills related to human performance. We are working together under a common banner to help neuro-optometry, vision rehabilitation, and vision performance professionals gain measurable results in less time, and with less effort.

Terry Booth

Executive Chairman

Adam Cegielski

Founder | CEO

Investor Relations

Email: [email protected]

Toll-free: 1 (844) 866-6162

https://www.eyecarrot.com/investors/

Forward looking information

Certain statements contained in this news release constitute “forward-looking information” as such term is used in applicable Canadian securities laws. Forward-looking information is based on plans, expectations, and estimates of management at the date the information is provided and is subject to certain factors and assumptions, including, that the Company’s financial condition and development plans do not change as a result of unforeseen events and that the Company obtains regulatory approval. Forward-looking information is subject to a variety of risks and uncertainties and other factors that could cause plans, estimates and actual results to vary materially from those projected in such forward-looking information. Factors that could cause the forward-looking information in this news release to change or to be inaccurate include, but are not limited to, the risk that any of the assumptions referred to prove not to be valid or reliable, that occurrences such as those referred to above are realized and result in delays, or cessation in planned work, that the Company’s financial condition and development plans change, and delays in regulatory approval, as well as the other risks and uncertainties applicable to the Company as set forth in the Company’s continuous disclosure filings filed under the Company’s profile at www.sedar.com . The Company undertakes no obligation to update these forward-looking statements, other than as required by applicable law.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Mary Meeker’s Fund Invests in India #Edtech Startup Byju’s – SPONSOR: BetterU Education Corp. $BTRU.ca $ARCL $CPLA $BPI $FC.ca

Posted by AGORACOM-JC at 9:45 PM on Sunday, June 28th, 2020

SPONSOR:  BetterU Education Corp. aims to provide access to quality education from around the world. The company plans to bridge the prevailing gap in the education and job industry and enhance the lives of its prospective learners by developing an integrated ecosystem. betterU / Ottolearn launch FREE COVID-19 mobile resource toolkit to fight the global crisis – Click here for more information.

Mary Meeker’s Fund Invests in India Edtech Startup Byju’s

  • Mary Meeker’s venture capital fund Bond Capital has backed online education startup Byju’s, marking its first investment in India.
  • The startup, which simplifies math and science concepts for K-12 students through games and videos, has seen tremendous growth over the past year

By: Saritha Rai, Bloomberg News

(Bloomberg) — Mary Meeker’s venture capital fund Bond Capital has backed online education startup Byju’s, marking its first investment in India.

The startup, which simplifies math and science concepts for K-12 students through games and videos, has seen tremendous growth over the past year. That has further accelerated with coronavirus lockdowns shutting schools and prompting parents, teachers and students to seek out online resources.

Byju’s has over 57 million registered students and more than 3.5 million paid subscribers, and has doubled revenues from 28 billion rupees ($370 million) in the last financial year.

Byju’s is “endorsed by millions of students” and is a clear leader in education technology, Meeker, a general partner at Bond, said in a funding announcement. Existing investors include Facebook founder Mark Zuckerberg’s Chan Zuckerberg Initiative and Sequoia Capital.

Source: https://www.bnnbloomberg.ca/mary-meeker-s-fund-invests-in-india-edtech-startup-byju-s-1.1456742

TransCanna $TCAN.ca Closes Non-Brokered Warrant Financing $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 6:04 PM on Thursday, June 25th, 2020
tcan-square
  • Issued 5,000,000 warrants in a non-brokered private placement at a price of $0.05 per warrant for gross proceeds of $250,000
  • There were no finders’ fees payable on this private placement

Vancouver, British Columbia–(June 25, 2020) – TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) (“TransCanna” or the “Company“) has issued 5,000,000 warrants in a non-brokered private placement at a price of $0.05 per warrant for gross proceeds of $250,000. There were no finders’ fees payable on this private placement.

The private placement is subject to the approval of the Canadian Securities Exchange (“CSE”) and the securities will be subject to a four-month hold period under securities laws. The Company intends to use the net proceeds from the private placement for working capital purposes.

Each warrant entitles the holder to purchase one common share of the Company, at an exercise price of $1.00 per share, for a period of two years from the date of issuance. The warrants are subject to an acceleration right that allows the Company to give notice of an earlier expiry date if the Company’s share price on the CSE (or such other stock exchange the Company’s shares may be trading on is equal to or greater than $1.30 for a period of 20 consecutive trading days.

The Company did not file a material change report more than 21 days before the expected closing of the private placement as the details of the private placement and the participation therein by related parties of the company were not settled until shortly prior to closing and the company wished to close on an expedited basis for sound business reasons and in a time frame consistent with usual market practices for transactions of this nature.

The Company also announces that it has granted 100,000 stock options to a consultant. The stock options are exercisable for a period of 3 years at an exercise price of $1.00. The stock options are being granted pursuant to the terms of the Company’s stock option plan and are subject to regulatory approval.

About TransCanna Holdings Inc.

TransCanna Holdings Inc. is a California based, Canadian listed, company building Cannabis-focused brands for the California lifestyle, through its wholly-owned California subsidiaries.

For further information, please visit the Company’s website at www.transcanna.com or email the Company at [email protected].

Bob Blink, CEO

604-349-3011

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF ANY SECURITIES DESCRIBED HEREIN

#Covid19 Impact on #Mhealth Applications Market is Estimated to Reach USD 100.2 billion by 2023 – SPONSOR: CardioComm Solutions $EKG.ca $ATE.ca $TLT.ca $OGI.ca $ACST.ca $IPA.ca

Posted by AGORACOM-JC at 5:42 PM on Thursday, June 25th, 2020

SPONSOR: CardioComm Solutions (EKG: TSX-V) – The heartbeat of cardiovascular medicine and telemedicine. Patented systems enable medical professionals, patients, and other healthcare professionals, clinics, hospitals and call centres to access and manage patient information in a secure and reliable environment.

Covid19 Impact on mHealth Applications Market is Estimated to Reach USD 100.2 billion by 2023

  • As per Market Research Future (MRFR), the global mHealth applications market is expected to reach USD 100.2 billion from 2017 to 2023
  • Global mHealth applications market is primarily driven by the increasing adoption of advanced technologies in healthcare sector and the need to reduce long waiting periods for specialists to access healthcare facilities

mHealth is one of the most advanced and disruptive trends in the healthcare sector that has been expanding at an exceptional rate over the last few years. mHealth changes the way traditional medical practices take place and creates a path for the future of healthcare. mHealth helps to track and manage health-related practices by using technologies such as Bluetooth, mobile network (GSM/ GPRS/3G/4 G), and Wi-Fi. Data collected by mHealth devices, such as mobile phones, tablets, laptops, and tablets, help medical professionals, consumers, and other users.

mHealth Applications Market Dynamics

The global mHealth applications market is primarily driven by the increasing adoption of advanced technologies in healthcare sector and the need to reduce long waiting periods for specialists to access healthcare facilities. The availability of mobile applications for users is experiencing rapid growth, particularly in healthcare applications that help consumers manage their illnesses, well-being, and chronic conditions. This increased role of patients, coupled with the increasing importance of keeping up-to-date information about their own health decisions, has contributed to an increase in the global adoption of mHealth applications.

The healthcare industry has moved towards a value-based care model, with mHealth becoming a widespread trend due to the advent of technologies such as remote monitoring, electronic medical records, and other communication platforms. The rising prevalence of disorders such as diabetes, hypertension, cancer, and obesity, as well as raising awareness of wellness and other preventive measures among patients, are expected to fuel the growth of the mHealth application industry.

The introduction of wearable devices from Fitbit, Apple, and Xiaomi have a positive impact on the market. Market growth appears to be positive, with increasing investment in wearable technology start-ups. These start-ups focus on categories of mHealth, such as personal safety, women’s health, and hydration monitoring, which promise exciting market prospects.

mHealth Applications Market Segmentation

The global market for mHealth applications has been segmented based on type, which includes monitoring applications, education & awareness, healthcare management, diagnosis & treatment, wellness & prevention, and others. The monitoring application segment had the largest market share of approximately 53.8% in 2016.

mHealth Applications Market Regional Analysis

Region-wise,the global mHealth applications market has been segmented into Europe, North America, Asia Pacific, and Middle East & Africa.

In 2016, Europe had the highest market share of 31.7% in the global market for mHealth applications, taking into account the regional market scenario.

The Asia Pacific is the second-largest and fastest-growing market in the global market for mHealth applications. APAC is forecast to rise at 33.7% CAGR in 2017-2023. Many Asian countries are adopting digital health strategies to manage healthcare delivery and deliver better outcomes. For example, the Digital India program aims to improve IT services to empower healthcare professionals. These initiatives are expected to make the Asia Pacific the fastest-growing segment in the forecast period.

North America is one of the leaders in the field of mhealth and is only behind the APAC. North America is estimated to cross USD 28762.1 million by 2023.

The Middle East and Africa were valued at USD 1334.9 in 2016 and is expected to rise at a steady pace over the forecast period.

Source: https://www.medgadget.com/2020/06/covid19-impact-on-mhealth-applications-market-is-estimated-to-reach-usd-100-2-billion-by-2023-size-share-clinical-health-data-stress-management-advance-technology-global-growth-factors-and-demand.html

CLIENT FEATURE: TransCanna Holdings $TCAN.ca Developing the Largest Multi-Purpose Cannabis Facility in California $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 4:12 PM on Thursday, June 25th, 2020
tcan-square

(CSE: TCAN) (FSE: TH8)

Why TransCanna?

  • $2M CAD Revenue April 2020
  • $24.6M CAD Revenue Run Rate solely from TransCanna test facility
  • $90M Annual Revenue expected from first full year upon completion of 196,000 Sq Ft Daly facility Q3 2021
  • Daly facility will be one of the largest cannabis facilities in California
  • Recently acquired two California companies,
    • High-end award winning edible producer Soldaze
    • Premium indoor cultivator and distributor Lyfted Farms
  • Lyfted Farms products sold in select Cookies Locations – The most recognizable name in high-end Cannabis.
  • 2019 California Cannabis sales over $3B, industry currently fragmented
  • Direct to dispensary model, cutting out the middleman
  • Announced an Inventory and Product Agreement  with Cali Plug UHCC for its highly anticipated inaugural retail location.
    • Cali Plug was founded in 2006 and is a significant influencer in the cannabis space, with approximately 200,000 Instagram followers (@caliplug)
  • Entered MOU with major agriculture firm KeyPlex, to create and market high quality bio-pesticides,
    • bio-fungicides, and fertilizers with micronutrients specifically created for the cannabis industry

WATCH OUR RECENT INTERVIEW

FULL DISCLOSURE: TransCanna Holdings is an advertising client of AGORA Internet Relations Corp.

CLIENT FEATURE: Eyecarrot Innovations $EYC.ca Creating Faster Brains Through Stronger Eyes $EYPT $KALA

Posted by AGORACOM-JC at 5:45 PM on Wednesday, June 24th, 2020
http://www.smallcapepicenter.com/eyc%20square.png

EYC: TSX-V

Trusted and used by some of the world’s top professional sports teams, including:

Why Eyecarrot?

  • Eyecarrot Has Already Started Commercializing Its Vision Therapy Platform
  • Company’s Vision Therapy Products Used In:
    • Over 1,500 Practices
    • 20 Countries
  • Flagship “Binovi” Is State-Of-The-Art Platform
    • Measures 14 Key Vision Skills
    • Essential For Maximizing Brain Performance
    • Shipped Over 400 Binovi Units (April 2020)
    • Goal Is 2,500 Binovi Units (End Of 2020)
  • Signed Sports Vision Partnership With Eli Wilson Goaltending
    • World Leader In Goaltending Development
    • 600 Active Goaltending Camp Participants
    • 50,000 Global Aspiring Goaltenders
  • Closed Major Financing In Q1 2020
  • Eyecarrot is now well positioned to further commercialize and capitalize on massive demand for Vision Therapy and Training For Athletes and Education

THE MARKET OPPORTUNITY

  • Vision Therapy captures 3% of a $36B Yearly Vision Market today
  • Vision Therapy will grow by 22% this year and account for 4% of the $39B Yearly Market by year end
  • Sights are set on disrupting the sports performance industry in 2020 while receiving engagement from leaders within the human performance – sport performance industry
  • The size of the sports performance market reached a value of nearly $488.5B in 2018, having grown at a compound annual growth rate (CAGR) of 4.3% since 2014
  • Expected to grow at a CAGR of 5.9% to nearly $614.1B by 2022

WATCH OUR RECENT INTERVIEW

Eyecarrot Innovations is an advertising client of AGORA Internet Relations Corp.

Nickel in batteries to take ‘significant’ market share – SPONSOR Tartisan #Nickel $TN.ca – $ROX.ca $FF.ca $EDG.ca $AGL.ca $ANZ.ca

Posted by AGORACOM-JC at 4:38 PM on Thursday, June 18th, 2020

SPONSOR: Tartisan Nickel (TN:CSE)  Kenbridge Property has a measured and indicated resource of 7.14 million tonnes at 0.62% nickel, 0.33% copper. Tartisan also has interests in Peru, including a 20 percent equity stake in Eloro Resources and 2 percent NSR in their La Victoria property. Click her for more information

Tc logo in black

Nickel in batteries to take ‘significant’ market share from 2023

  • “We see total nickel demand from the battery market (all end-uses) much higher than that with the ongoing trend towards higher nickel cathode technology in EVs,” Miller said.

By: Angela East

The rapidly growing demand for more nickel in electric vehicle (EV) batteries is expected to see the base metal take a much bigger market share in just three years.

“In terms of when the shift towards nickel intense cathodes starts to take effect, we expect batteries using high nickel cathodes (namely NCM 811) start to really develop significant market share from 2023 onwards,” Benchmark Mineral Intelligence analyst Gregory Miller told Stockhead.

NCM 811 has a chemistry make-up of 80 per cent nickel, 10 per cent cobalt and 10 per cent manganese.

For some time now, car and battery makers have been working to reduce the amount of cobalt that goes into their batteries because it is one of the most expensive parts and there is a shortage of the commodity.

“Some of this technology is just starting to filter into the industry now following many years of development yet it still faces technical challenges in being able to deploy into the EV market,” Miller explained.

“By increasing nickel in the cathode, you decrease the life of the battery (i.e. how many cycles you can put it through) and increase safety issues linked to thermal stability.

“This transition will be significant for the industry as demand grows, by 2035 demand could be roughly as big as the industry was in 2019.”

Major players like South Korean battery materials maker Posco are now producing cathodes with greater nickel content to meet demand for greater energy density and longer driving range in the next generation of EVs.

A recently completed 25,000-tonne-per-year plant expansion will mass produce cathodes with 65 per cent nickel content, Posco says.

Fellow South Korean battery maker Samsung says that nickel will make up more than 80 per cent of the cathode materials in its fifth-generation EV batteries when commercial production begins in early 2021.

While Wood Mackenzie is predicting demand for nickel sulphate from the EV market to reach around 800,000 tonnes a year by 2035, Benchmark Minerals Intelligence is expecting it to far exceed that.

“We see total nickel demand from the battery market (all end-uses) much higher than that with the ongoing trend towards higher nickel cathode technology in EVs,” Miller said.

“In Benchmark Minerals most recent quarterly nickel forecast we see nickel demand from lithium-ion batteries reaching 2,250,000 tonnes by 2035.”

Market could open up for multiple nickel products

Miller says it has been suggested that the rise of EV demand could result in a “bifurcation” of the nickel market, with a split between higher-grade nickel for the EV industry and lower-grade (mainly ferronickel and nickel pig iron) nickel to supply stainless steel mills.

But this all depends on the success of high-pressure acid leach (HPAL) operations being built in South East Asia.

“The history of HPAL operations is littered with technical and operational challenges, and if these projects fail to bring sufficient nickel units to market, a wider spectrum of nickel feedstocks may become economically viable in the production of nickel sulphate due to a higher price environment,” Miller explained.

However, the nickel sulphate market is expected to remain in oversupply for a few years yet.

“Benchmark Minerals forecasts the nickel sulphate market to remain in surplus until 2024, where we expect a deficit to emerge thereafter where rapid demand growth will set in as EV penetration rates rise quickly,” Miller said.

“This is likely to be exacerbated by increasing use of high nickel cathodes (NCM 811).”

Spurring a price rise

Although the nickel price is on an upward trend, it is still off the five-and-a-half-year high of $US18,620 ($27,097) per tonne it reached in September last year.

It currently sits at $US12,930 per tonne, only about 17 per cent higher than its recent bottom in March.

However, longer term Benchmark sees prices rising to between $US15,000 and $US20,000 per tonne as supply struggles to match the significant ramp up in demand from EV’s over the coming decade.

“Indeed, with the next generation of supply suitable for use in batteries set to come from capital intensive HPAL projects in South East Asia, a higher pricing environment will be necessary to incentivise both the development and operation of these projects.”

Source: https://stockhead.com.au/resources/nickel-in-batteries-to-take-significant-market-share-from-2023/